Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”

Detalles Bibliográficos
Autores principales: Imamura, Hiroshi, Hasegawa, Kiyoshi, Soejima, Yuji, Saiura, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485984/
https://www.ncbi.nlm.nih.gov/pubmed/36158589
http://dx.doi.org/10.1159/000525065
_version_ 1784792178344591360
author Imamura, Hiroshi
Hasegawa, Kiyoshi
Soejima, Yuji
Saiura, Akio
author_facet Imamura, Hiroshi
Hasegawa, Kiyoshi
Soejima, Yuji
Saiura, Akio
author_sort Imamura, Hiroshi
collection PubMed
description
format Online
Article
Text
id pubmed-9485984
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-94859842022-09-23 Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study” Imamura, Hiroshi Hasegawa, Kiyoshi Soejima, Yuji Saiura, Akio Liver Cancer Letter to the Editor S. Karger AG 2022-05-13 /pmc/articles/PMC9485984/ /pubmed/36158589 http://dx.doi.org/10.1159/000525065 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Letter to the Editor
Imamura, Hiroshi
Hasegawa, Kiyoshi
Soejima, Yuji
Saiura, Akio
Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title_full Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title_fullStr Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title_full_unstemmed Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title_short Regarding “Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study”
title_sort regarding “postresection period-specific hazard of recurrence as a framework for surveillance strategy in patients with hepatocellular carcinoma: a multicenter outcome study”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485984/
https://www.ncbi.nlm.nih.gov/pubmed/36158589
http://dx.doi.org/10.1159/000525065
work_keys_str_mv AT imamurahiroshi regardingpostresectionperiodspecifichazardofrecurrenceasaframeworkforsurveillancestrategyinpatientswithhepatocellularcarcinomaamulticenteroutcomestudy
AT hasegawakiyoshi regardingpostresectionperiodspecifichazardofrecurrenceasaframeworkforsurveillancestrategyinpatientswithhepatocellularcarcinomaamulticenteroutcomestudy
AT soejimayuji regardingpostresectionperiodspecifichazardofrecurrenceasaframeworkforsurveillancestrategyinpatientswithhepatocellularcarcinomaamulticenteroutcomestudy
AT saiuraakio regardingpostresectionperiodspecifichazardofrecurrenceasaframeworkforsurveillancestrategyinpatientswithhepatocellularcarcinomaamulticenteroutcomestudy

Ejemplares similares